European Case Law Identifier: | ECLI:EP:BA:2010:T036509.20100414 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 14 April 2010 | ||||||||
Case number: | T 0365/09 | ||||||||
Application number: | 99968778.3 | ||||||||
IPC class: | C08B 37/08 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Cross-linked hyaluronic acids and medical uses thereof | ||||||||
Applicant name: | Sigmar Italia S.p.A. | ||||||||
Opponent name: | Fidia Farmaceutici S.P.A. | ||||||||
Board: | 3.3.03 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Inventive step - ex post facto analysis Inventive step - non-obvious combination of known features Inventive step - problem and solution Res judicata |
||||||||
Catchwords: |
Res judicata under EPC 2000 (reasons 2 to 2.2) |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t090365eu1.html
Date retrieved: 17 May 2021